CME faces backlash over legal challenge to crypto futures

The conflict centers on CME’s lawsuit against the CFTC and Chairman Michael Selig, which challenges the regulatory classification of perpetual futures. CME argues these products should be regulated as swaps under the Dodd-Frank Act rather than as standard futures. Outgoing CME CEO Terrence Duffy maintains that the regulator bypassed necessary rulemaking procedures, creating an uneven playing field for established firms.

Hyperliquid’s critique frames the dispute differently, suggesting the exchange is acting as a "petty monopolist" threatened by the first genuine innovation in U.S. derivatives in over a decade. Data from Better Markets reinforces this narrative, highlighting that CME’s near-total control of domestic exchange-traded derivatives leaves little room for alternative platforms. According to Chervinsky, the move is an "unforced error" that highlights a broader resistance to market evolution.

As the litigation proceeds, both the CFTC and the SEC have launched a joint public consultation to address long-standing ambiguities regarding the classification of modern derivatives under Title VII. CFTC Chairman Michael Selig recently remarked that vested interests frequently fear the future, signaling that regulators may be looking to move past the definitions that CME currently relies upon to maintain its market position.